Cidara Therapeutics (20D0.F) Q4 2024 Earnings

7NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-18.18
-12.82
-7.45
-2.09

Details

Expected EPS
-3.9346925
Actual EPS
-2.2682345
Surprise EPS
1.67
Surprise Percent
+42.35%

Description

Cidara Therapeutics (20D0.F) has reported earnings of -2.2682345 per share for Q4 2024.

0 Comments

Share your thoughts